HUTCHMED (China) (HCM) Gains from Sales and Divestitures (2020 - 2021)
Historic Gains from Sales and Divestitures for HUTCHMED (China) (HCM) over the last 6 years, with Q4 2024 value amounting to $10000.0.
- HUTCHMED (China)'s Gains from Sales and Divestitures fell 8837.21% to $10000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $10000.0, marking a year-over-year decrease of 8837.21%. This contributed to the annual value of $10000.0 for FY2024, which is 8837.21% down from last year.
- As of Q4 2024, HUTCHMED (China)'s Gains from Sales and Divestitures stood at $10000.0, which was down 8837.21% from $86000.0 recorded in Q4 2023.
- In the past 5 years, HUTCHMED (China)'s Gains from Sales and Divestitures registered a high of $111000.0 during Q4 2022, and its lowest value of $10000.0 during Q4 2024.
- Its 5-year average for Gains from Sales and Divestitures is $72400.0, with a median of $85000.0 in 2020.
- Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first soared by 40000.0% in 2020, then tumbled by 8837.21% in 2024.
- HUTCHMED (China)'s Gains from Sales and Divestitures (Quarter) stood at $85000.0 in 2020, then dropped by 17.65% to $70000.0 in 2021, then skyrocketed by 58.57% to $111000.0 in 2022, then dropped by 22.52% to $86000.0 in 2023, then crashed by 88.37% to $10000.0 in 2024.
- Its last three reported values are $10000.0 in Q4 2024, $86000.0 for Q4 2023, and $111000.0 during Q4 2022.